According to information released by the newspaper El Comercio, “Nestlé has joined the trend for organic products and has launched a new range that has repercussions on Asturias, as 25% of the production will take place in the plant owned by the Swiss company in Sevares, where jars of baby food and liquid milks are made, employing around two hundred people. The new range includes purees, pouches, baby cereal, dairy desserts and biscuits, but the Piloña factory will specifically manufacture the six varieties of baby food in jars that are being launched: three of fruit, three of meat.”

On the other hand, the company published a press release on 23^rd May giving information about the launch and growth forecasts:

– The Company envisages that in five years, the new organic range will contribute between 10% and 15% of its turnover. In terms of production, 65% of these new products will be manufactured in Nestlé España’s Spanish factories.

– The main organic products that the company has just released into the market are: the complete range of Naturnes Bio baby food, Solís fried tomato sauce, Organic Bonka ground coffee, Nescafé Gold Organic instant coffee, and three varieties of Nescafé Dolce Gusto capsules.

– Other new launches such as the Litoral pulse salads (appearing on shelves this May), the new Garden Gourmet varieties based on vegetable protein, and Nestlé Sin Azúcares Añadidos (No Added Sugar) chocolates, complete a portfolio of products that respond to new trends.

The CEO of Nestlé España, Laurent Dereux, revealed in a press meeting that: “consumer demand is increasingly for healthier and more sustainable products. In this respect, we believe that these organic products will contribute between 10% and 15% of Nestlé España’s turnover within five years. Furthermore, in terms of production, I am particularly proud to state that 65% of our organic products will be produced in our Spanish factories in Miajadas (Caceres), Sebares (Asturias) and Reus (Tarragona)”.

Sources: El Comercio, Nestlé-press release

THE HEALTHCARE SECTOR IN ASTURIAS

The medicine and bio-sanitary industries are strategic sectors in Asturias.
With the drive of infrastructures such as the Central University Hospital of Asturias (HUCA), support for R&D projects from the University of Oviedo and the

notable innovative activities undertaken by the Fernández-Vega Ophthalmology Institute, Asturias demonstrates its marked support for the development of biotechnology, bio-information and biomedicine.

Download PDF

1433

MILION EUROS
2015 budget

16000

Direct employment
positions

38

Regional budget

250

Connected to over
250 companies
from various
sectors

Asturias is a point of reference in Europe for active ageing.
The European Commission has chosen Asturias as one of the Reference Sites of Europe in innovation regarding Active and Healthy Ageing.

innovation & technology

Technology Centres, R&D&I Institutions, Clusters

HUCA. CENTRAL UNIVERSITY HOSPITAL OF ASTURIAS

The HUCA was created in 1989 through an agreement between the Autonomous government and the National Healthcare Institution (INSALUD), fusing the management of three centres: the Hospital Nuestra Señora de Covadonga, the Instituto Nacional de Silicosis, both from the Social Security, and the Hospital General de Asturias, owned by the Autonomous Community. HUCA is currently accountable to the SESPA.
The specific agreement signed between the University of Oviedo, the INSALUD and the Principality of Asturias which was approved in 1990, gives the HUCA its title as a University Hospital.
In 2013 the HUCA finalised the construction work undertaken on its current building in Oviedo. The new HUCA forms a unique space for attendance, teaching and research, generating synergies with the surrounding infrastructures: FINBA, the Public Healthcare Laboratory and the Vivero incubator of health science companies.
It has an outstanding strategy for developing Healthcare Information Systems (EDESIS) at the core of the project to computerise the region’s healthcare centres. Among the projects launched by EDESIS are the integrated care information, the identification system for people and resources, departmental applications for pharmacies, laboratories and digital radiology image, and electronic prescriptions. Regarding the care aspect, a particular emphasis is placed on development of devices and sensors used in the follow-up of distance biological indicators and their indication within the centre HIS system and the remote control of environmental parameters.

FINBA. FOUNDATION FOR BIO-SANITARY RESEARCH AND INNOVATION ASTURIAS

The FINBA is the body which controls the bio-medical research of excellence in Asturias. The organisation is backed by the Principality of Asturias in alliance with the University of Oviedo, supported by various companies which participate either as employers or benefactors.
It emerged with the aim of driving forward bio-medical research, benefitting from synergies with the Central University Hospital of
Asturias (HUCA), with the objective of taking full advantage of the Asturian healthcare’s wealth of knowledge and promoting collaborative work between the research teams.

BUSINESS INCUBATOR FOR HEALTH SCIENCES

A centre designed to house business initiatives in the field of R&D&i in Health Sciences, very close to the Central University Hospital of Asturias (HUCA). An initiative led by the Oviedo City Council.

BIOBANCO

The BioBanco has over 60,000 human biological samples available to be used in research projects. It belongs to the National network of BioBanks from the Instituto de Salud Carlos III, which also forms a part of the European biobanks BBMRI network-Biobanking and Biomolecular Resources Research Infrastructure.

The BioBanco is formed of three subunits: the Brain Bank (centralised in the hub of the HUCA), the DNA, Plasma and Cell Bank (centralised in the hub of the HUCA) and the Tumour Bank (formed by a network of Tumour Banks in different hospitals across Asturias).

OBSA. HEALTH OBSERVATORY IN ASTURIAS

The regional government promotes three fundamental lines within the OBSA: the generation of a knowledge area about health information in Asturias; the guarantee that this information is comprehensible and that it reaches as many social representatives as possible, and finally to link health information from indicators to the different community activities undertaken in the field of health that are being developed in Asturias.
It is a project undertaken in collaboration with the School of Public Health and Medicine at the University of Wisconsin, which are currently participating in the County Health rankings model in the United States.

UNIVERSITY OF OVIEDO

Education in Biomedicine and Health at the University of Oviedo is among the most prestigious in Spain and houses numerous researches related to bio-technology, in particular at the heart of the IUBA (University Institute of Bio‑Technology), the IUOPA (University Institute of Oncology of the Principality of Asturias) and the INEUROPA (University Institute of Neurosciences of the Principality of Asturias).
The Cluster of Biomedicine and Health, brings together over 70 groups that work at the forefront of current knowledge, following five basic lines of research:

Genomics and proteomics related to cancer and ageing
Brain development and degeneration
Biomedicine and the development of drugs
Regenerative medicine, transplants and implants
Research in food production and food technology

The scientific-technical research facilities are accessible to research centres and the general public (companies and private individuals). Among the areas related to the field of health‑biotechnology, are the:

Biotechnological and Biomedical Trials Unit
Food Technology Unit
Animal Facility and Preclinical Trials Unit
Environmental Trials Unit

BIOINCUBADORA PARQUE TECNOLÓGICO DE ASTURIAS

BIOINCUBATOR ASTURIAS TECHNOLOGY PARK

The Bio-incubator at the Asturias Technology Park for the Economic Development Agency, driven by the Principality of Asturias (IDEPA) and managed by the CEEI, is an innovative space offering accommodation and specific equipment adapted to the needs of “bio” companies.
Via the BIOCEEI ASTURIAS programme, the IDEPA and the CEEI promote the capture and growth of business projects in the field of life sciences. Once these initiatives have been detected, they are accompanied through a process of guidance and personalised training, whilst participating at the same time in a “biotech” project acceleration programme.

FIO. FUNDACIÓN DE INVESTIGACIÓN OFTALMOLÓGICA

FIO. OFTALMOLOGICAL RESEARCH FOUNDATION

Sponsored by the Fernández-Vega Ophthalmology Institute the FIO develops translational research in the ocular and cornea area, the genetics of ocular diseases and ocular neurobiology with top-level international professionals.

Bio-printing: theAsturias Technological Production and Industrial Design Centre (PRODINTEC) is abenchmark in the field of 3D bio-printing in terms of technological development and experience in R&D projects through its roll to roll pilot line, thanks to over 10 years of experience in additive manufacturing technologies. The objective is to one day use the same additive manufacturing techniques to produce human tissue and organs.

education

The University of Oviedo offers new courses adapted to the European Area of Higher Education with qualifications that cover most fields of knowledge. Some 30 % of its over 22,000 registered students follow technical degree courses (Biotechnology, Biology, Geology, Chemistry, Physics, Mathematics, Mining and Energetic Resource Engineering, Forestry and Natural Environment Engineering, etc.).
The following University of Oviedo Master’s Degrees related to the development of the health sector are outstanding:

International Master’s Degree in Analytical
and Bio-analytical Sciences
Master’s Degree in Environmental andHealth Bio-technology
Master’s Degree in Food Bio-technology
Master’s Degree Biology and Reproductive Technology
Master’s Degree in Chemistry and Sustainable Development
Master’s Degree in Biomedicine and Molecular Oncology
Master’s Degree in Nursing of Emergency and Critical Care
Master’s Degree in Neuroscience Research

Accredited Vocation Training, with 17,000 registered students, more than the 35 % following technical degrees, completes the technical qualification of the Asturian workforce, combining theoretical training with work experience undertaken in companies.

succes stories

CAPSA

Leading company in the national dairy sector and the first Spanish dairy
company to be awarded the AENOR Healthy Workplace Certification.
The company produces milk, enriched dairy products, cream, cheeses and yoghurts.

Leadership in innovation is one of its cornerstones, working alongside other leading companies, universities and bodies to support R&D&i in projects with objectives such as discovering food products that may reduce the risk of chronic pathologies from middle age, and identifying factors which influence human microbiota and its role in obesity and associated disorders.

BAYER

Multinational producer of raw materials for the pharmaceutical sector.
The Bayer acetylsalicylic acid plant in Asturias is where 100 % of the active
ingredient for Aspirin is produced. Some 200 million units of aspirin are consumed around the world each day.

Additionally, and as a result of its high levels of competitiveness, experience and quality, the Bayer plant in Asturias, plans to take on the worldwide production of an active ingredient for an anti-parasitic drug for pets.

IMOMA

The IMOMA is a private initiative by Corporación Masaveu, Cajastur and
Medicina Asturiana to fight against cancer. Its care activities are based around three cornerstones: coordinated, relevant and personal attention towards patients, the integration of molecular biology advances in clinical protocol, and backing the very latest generation radiotherapy.

Instituto Oftalmológico Fernández-Vega

The Fernández-Vega Ophthalmology Institute undertakes specialised care activity in the field of Ophthalmology, attending around 100,000 patients annually, of which some 65,000 are from outside Asturias.
Alongside this activity, it carries out clinical research to assess results, with a view to continuously improve and incorporate new medicalsurgical treatments, improving traditional services and offering new products in the fields of ophthalmology and vision sciences, based on its R&D&i projects.